Trust Company of Vermont’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.8M Buy
+212,013
New +$49.4M 2.01% 11
2025
Q4
$39.5M Buy
191,009
+12,985
+7% +$2.57M 1.65% 11
2025
Q3
$33M Buy
178,024
+5,241
+3% +$898K 1.44% 13
2025
Q2
$26.4M Buy
172,783
+15,756
+10% +$2.42M 1.24% 17
2025
Q1
$26M Sell
157,027
-2,727
-2% -$427K 1.3% 16
2024
Q4
$23.1M Sell
159,754
-500
-0.3% -$77.5K 1.12% 19
2024
Q3
$26M Buy
160,254
+360
+0.2% +$57.4K 1.3% 19
2024
Q2
$23.4M Sell
159,894
-786
-0.5% -$117K 1.27% 16
2024
Q1
$25.4M Buy
160,680
+18,971
+13% +$3.02M 1.42% 12
2023
Q4
$22.2M Sell
141,709
-16,720
-11% -$2.56M 1.48% 11
2023
Q3
$24.7M Buy
158,429
+2,520
+2% +$416K 1.67% 8
2023
Q2
$25.8M Sell
155,909
-676
-0.4% -$109K 1.68% 8
2023
Q1
$24.3M Buy
156,585
+2,449
+2% +$395K 1.69% 8
2022
Q4
$27.2M Buy
154,136
+5,800
+4% +$1M 2% 5
2022
Q3
$24.2M Buy
148,336
+2,126
+1% +$360K 1.92% 7
2022
Q2
$26M Buy
146,210
+2,036
+1% +$363K 1.98% 6
2022
Q1
$25.6M Sell
144,174
-1,936
-1% -$329K 1.73% 8
2021
Q4
$25M Sell
146,110
-1,192
-0.8% -$195K 1.58% 8
2021
Q3
$23.8M Buy
147,302
+495
+0.3% +$84.5K 1.69% 6
2021
Q2
$24.2M Buy
146,807
+3,254
+2% +$539K 1.69% 6
2021
Q1
$23.6M Sell
143,553
-752
-0.5% -$122K 1.77% 6
2020
Q4
$22.7M Buy
144,305
+1,733
+1% +$256K 1.81% 6
2020
Q3
$21.2M Buy
142,572
+592
+0.4% +$87.6K 1.94% 6
2020
Q2
$20M Sell
141,980
-34,014
-19% -$4.96M 1.97% 5
2020
Q1
$23.1M Sell
175,994
-2,346
-1% -$333K 2.16% 4
2019
Q4
$26M Sell
178,340
-2,110
-1% -$286K 1.96% 4
2019
Q3
$23.3M Buy
180,450
+2,447
+1% +$322K 1.87% 5
2019
Q2
$24.8M Buy
178,003
+855
+0.5% +$118K 2.06% 4
2019
Q1
$24.8M Sell
177,148
-620
-0.3% -$83K 2.13% 4
2018
Q4
$22.9M Sell
177,768
-4,099
-2% -$572K 2.22% 2
2018
Q3
$25.1M Sell
181,867
-1,754
-1% -$233K 2.12% 4
2018
Q2
$22.3M Buy
183,621
+2,916
+2% +$364K 2% 4
2018
Q1
$23.2M Sell
180,705
-2,447
-1% -$331K 2.19% 3
2017
Q4
$25.6M Sell
183,152
-5,121
-3% -$713K 2.38% 2
2017
Q3
$24.5M Sell
188,273
-2,392
-1% -$317K 2.43% 2
2017
Q2
$25.2M Sell
190,665
-1,627
-0.8% -$208K 2.59% 1
2017
Q1
$23.9M Buy
192,292
+15,569
+9% +$1.86M 2.59% 1
2016
Q4
$20.4M Buy
176,723
+17,472
+11% +$2.02M 2.35% 2
2016
Q3
$18.8M Sell
159,251
-2,229
-1% -$270K 2.36% 1
2016
Q2
$19.6M Buy
161,480
+2,828
+2% +$321K 2.6% 1
2016
Q1
$17.2M Buy
158,652
+988
+0.6% +$102K 2.4% 1
2015
Q4
$16.2M Buy
157,664
+8,904
+6% +$895K 2.32% 1
2015
Q3
$13.9M Buy
148,760
+408
+0.3% +$39.5K 2.16% 3
2015
Q2
$14.5M Buy
148,352
+3,580
+2% +$359K 2.1% 3
2015
Q1
$14.6M Sell
144,772
-435
-0.3% -$44.2K 2.12% 4
2014
Q4
$15.2M Sell
145,207
-891
-0.6% -$93.9K 2.21% 2
2014
Q3
$15.6M Buy
146,098
+1,417
+1% +$147K 2.36% 2
2014
Q2
$15.1M Sell
144,681
-807
-0.6% -$81.6K 2.34% 2
2014
Q1
$14.3M Buy
145,488
+750
+0.5% +$69.5K 2.34% 2
2013
Q4
$13.3M Sell
144,738
-206
-0.1% -$19K 2.22% 2
2013
Q3
$12.6M Buy
144,944
+1,761
+1% +$158K 2.31% 2
2013
Q2
$12.3M Buy
+143,183
New +$12.2M 2.4% 2

Other funds holding JNJ

Trust Company of Vermont's JNJ Position: Q2 2026 in Review

Trust Company of Vermont opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 212,013 shares worth $53.8M. The stake represents 2.01% of the portfolio and ranks #11 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in JNJ as recently as Q4 2025.

Trust Company of Vermont first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 3,160 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Trust Company of Vermont held 212,013 shares of Johnson & Johnson worth $53.8M as of Q2 2026.
  • Johnson & Johnson was a new Trust Company of Vermont position in Q2 2026.
  • Johnson & Johnson made up 2.01% of Trust Company of Vermont's portfolio in Q2 2026, its #11 holding.
  • Trust Company of Vermont first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 3,160 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.